A revolutionary cancer treatment could transform autoimmune disease

3 days ago

A woman with multiple sclerosis experienced significant life limitations despite medications.
She enrolled in a CAR T cell therapy clinical trial for autoimmune disease treatment.
CAR T therapy, originally for cancer, is being tested for various autoimmune conditions.
The therapy aims to reset the immune system by targeting self-attacking cells.
There are uncertainties about effectiveness, duration of benefits, and long-term side effects.
The patient underwent treatment with awareness of risks and hope for improvement.

Hasty Briefsbeta